Effects of immunosuppressive therapy on wound healing

International Wound Journal

Volumn 10, Issue 1, 2013, Pages 98-104

  Bootun, Roshan ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Immunosuppressive agents; Wound healing

Indexed keywords

AZATHIOPRINE; COLLAGEN; CYCLOSPORIN; CYCLOSPORIN A; EVEROLIMUS; FIBROBLAST GROWTH FACTOR; FIBRONECTIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; TACROLIMUS; THROMBIN; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ARTICLE; BLOOD CLOTTING; CYTOKINE RELEASE; EXTRACELLULAR MATRIX; FIBROBLAST; HEMOSTASIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SCAR FORMATION; SIGNAL TRANSDUCTION; THROMBOCYTE; WOUND COMPLICATION; WOUND HEALING;

ANIMALS; AZATHIOPRINE; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYCOPHENOLIC ACID; RATS; SIROLIMUS; SWINE; TACROLIMUS; WOUND HEALING; WOUNDS AND INJURIES;

EID: 84872606428     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2012.00950.x     Document Type: Article

References (33)

1. Enoch S, Leaper DJ. Basic science of wound healing. Surgery 2005;23:37-42.
2. Schultz G. Molecular regulation of wound healing. In: Bryant R, editor. Acute and chronic wounds: nursing management, 3rd edn. St Louis: Mosby, 2007:82-99.
3. Ekici Y, Emiroglu R, Ozdemir H, Aldemir D, Karakayali H, Haberal M. Effect of rapamycin on wound healing: an experimental study. Transplant Proc 2007;39:1201-3.
4. Li J, Chen J, Kirsner R. Pathophysiology of acute wound healing. Clin Dermatol 2007;25:9-18.
5. Broughton G II, Janis JE, Attinger CE. The basic science of wound healing. Plast Reconstr Surg 2006;117(7 Suppl):12S-34S.
6. Martin P. Wound healing - aiming for perfect skin regeneration. Science 1997;276:75-81.
7. Smith JM, Nemeth TL, McDonald RA. Current immunosuppressive agents: efficacy, side effects, and utilization. Pediatr Clin North Am 2003;50: 1283-300.
8. Gerber DA, Bonham CA, Thomson AW. Immunosuppressive agents: recent developments in molecular action and clinical application. Transplant Proc 1998;30:1573-9.
9. Bierer BE, Hollander G, Fruman D, Burakoff SJ. Cyclosporine-A and FK506 - molecular mechanisms of immunosuppression and probes for transplantation biology. Curr Opin Immunol 1993;5:763-73.
10. Suthanthiran M, Morris RE, Strom TB. Immunosuppressants: cellular and molecular mechanisms of action. Am J Kidney Dis 1996;28:159-72.
11. Al Rifai A, Prasad N, Shuttleworth E, McBurney H, Pushpakom S, Robinson A, Newman W, Campbell S. Natural history of azathioprine-associated lymphopenia in inflammatory bowel disease patients: a prospective observational study. Eur J Gastroenterol Hepatol 2011;23:153-8.
12. Lipsky JJ. Mycophenolate mofetil. Lancet 1996;348:1357-9.
13. Gummert JF, Ikonen T, Morris RE. Newer immunosuppressive drugs: a review. J Am Soc Nephrol 1999;10:1366-80.
14. Stallone G, Infante B, Grandaliano G, Gesualdo L. Management of side effects of sirolimus therapy. Transplantation 2009;87:S23-6.
15. Stypmann J, Engelen MA, Eckernkemper S, Amler S, Gunia S, Sindermann JR, Rothenburger M, Rukosujew A, Drees G, Welp HA. Calcineurin inhibitor-free immunosuppression using everolimus (Certican) after heart transplantation: 2 years' follow-up from the University Hospital Munster. Transplant Proc 2011;43:1847-52.
16. Stolzenburg T, Ljungmann K, Christensen H. The effect of azathioprine on anastomotic healing: an experimental study in rats. Dis Colon Rectum 2007;50:2203-8.
17. Baum CL, Arpey CJ. Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol Surg 2005;31:674-86; discussion 86.
18. Fishel R, Barbul A, Wasserkrug HL, Penberthy LT, Rettura G, Efron G. Cyclosporine A impairs wound healing in rats. J Surg Res 1983;34:572-5.
19. Hasegawa T, Sumiyoshi K, Tsuchihashi H, Nakao A, Ogawa H. FK506 inhibits the enhancing effects of TGF-beta on wound healing in a rabbit dermal ulcer model. J Dermatol Sci 2007;47:37-40.
20. Sikas N, Imvrios G, Takoudas D, Gakis D, Papanikolaou V. Mycophenolate mofetil impairs the integrity of colonic anastomosis. J Surg Res 2006;134:168-72.
21. Zeeh J, Inglin R, Baumann G, Dirsch O, Riley NE, Gerken G, Buchler MW, Egger B. Mycophenolate mofetil impairs healing of left-sided colon anastomoses. Transplantation 2001;71:1429-35.
22. Gaber MW, Aziz AM, Shang X, Penmetsa R, Sabek OM, Yen MRT, Gaber LW, Moore LW, Gaber AO. Changes in abdominal wounds following treatment with sirolimus and steroids in a rat model. Transplant Proc 2006;38:3331-2.
23. Kahn D, Spearman CW, Mall A, Shepherd E, Engelbrecht G, Lotz Z, Tyler M. The effect of rapamycin on the healing of the ureteric anastomosis and wound healing. Transplant Proc 2005;37:830-1.
24. van der Vliet JA, Willems MCM, de Man BM, Lomme RMLM, Hendriks T. Everolimus interferes with healing of experimental intestinal anastomoses. Transplantation 2006;82:1477-83.
25. Huang W-C, Liao S-K, Wallace CG, Chang N-J, Lin J-Y, Wei F-C. Greater efficacy of tolerance induction with cyclosporine versus tacrolimus in composite tissue allotransplants with less myeloablative conditioning. Plast Reconstr Surg 2011;127:1141-8.
26. Dean PG, Lund WJ, Larson TS, Prieto M, Nyberg SL, Ishitani MB, Kremers WK, Stegall MD. Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus. Transplantation 2004;77:1555-61.
27. Campistol JM, Cockwell P, Diekmann F, Donati D, Guirado L, Herlenius G, Mousa D, Pratschke J, San Millan JCR. Practical recommendations for the early use of m-TOR inhibitors (sirolimus) in renal transplantation. Transplant Int 2009;22:681-7.
28. Zakliczynski M, Nozynski J, Kocher A, Lizak MK, Zakliczynska H, Przybylski R, Wojarski J, Zembala M. Surgical wound-healing complications in heart transplant recipients treated with rapamycin. Wound Repair Regen 2007;15:316-21.
29. Albano L, Berthoux F, Moal M-C, Rostaing L, Legendre C, Genin R, Toupance O, Moulin B, Merville P, Rerolle J-P, Bayle F, Westeel PF, Glotz D, Kossari N, Lefrancois N, Charpentier B, Blanc A-S, Di Giambattista F, Dantal J, Group RAS. Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus. Transplantation 2009;88:69-76.
30. Burgos FJ, Pascual J, Quicios C, Marcen R, Fernandez A, Lopez Fando L, Ortuno J. Post-kidney transplant surgical complications under new immunosuppressive regimens. Transplant Proc 2006;38:2445-7.
31. Valente JF, Hricik D, Weigel K, Seaman D, Knauss T, Siegel CT, Bodziak K, Schulak JA. Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation. Am J Transplant 2003;3:1128-34.
32. Brewer JD, Otley CC, Christenson LJ, Phillips PK, Roenigk RK, Weaver AL. The effects of sirolimus on wound healing in dermatologic surgery. Dermatol Surg 2008;34:216-23.
33. Grim SA, Slover CM, Sankary H, Oberholzer J, Benedetti E, Clark NM. Risk factors for wound healing complications in sirolimus-treated renal transplant recipients. Transplant Proc 2006;38:3520-3.